Pneumonia treatment with vaccines instead of antibiotics

November 21, 2017, University of Zurich
The bacteria can persist in the upper respiratory tract. Credit: vgajic / iStock

Mycoplasma bacteria are one of the most common causes of bacterial pneumonia in children. It is still unclear how the disease develops. Researchers from the University Children's Hospital Zurich and UZH have now demonstrated that there are specific immune cells, so-called B cells, which are crucial for recovery from the infection.

The antibodies produced by these cells eliminate mycoplasma in the lungs, whereas these bacteria can persist in the upper respiratory tract. The team of researchers cultured the bacteria with a fluorescent dye and were thus for the first time able to visually track the pathogen in the and upper respiratory tract during an . The findings from the newly developed mouse model mimic clinical observations in children, whose upper respiratory tracts still contained mycoplasma following an infection.

Different immune responses in the lung and upper respiratory tract

Infectious disease specialist Patrick Meyer Sauteur showed together with the international team that there are significant differences between the lung and the upper respiratory tract in the immune response after an infection. The researchers found more so-called IgM and IgG antibodies in the lung as well as an increase and activation of B cells in local lymph nodes – which meant that pathogens were able to be eliminated within weeks. In contrast, in the upper respiratory tract they found IgA antibodies but no activation of B cells, which corresponds to the observed persistence of the pathogen at this site. In the end, experiments carried out with B cell-deficient mice demonstrated that the transfer of into these mice effectively eliminated the bacteria in the lung, but was not able to clear the bacteria in the .

"This data is the first proof that the antibody response is crucial to clear pulmonary infections caused by mycoplasma," says Patrick Meyer Sauteur. These findings may help develop specific vaccines that elicit antibody responses to protect from infection: "Our work paves the way for the development of vaccines against mycoplasma. Target groups for such vaccines would include young children without treatment alternatives as a result of the emerging resistance to antibiotics against mycoplasma in certain countries," says Meyer Sauteur.

Explore further: Respiratory tract bacterium uncovered as trigger for serious nervous system disease

More information: Patrick M Meyer Sauteur et al. The role of B cells in carriage and clearance of Mycoplasma pneumoniae from the respiratory tract of mice, The Journal of Infectious Diseases (2017). DOI: 10.1093/infdis/jix559

Related Stories

Respiratory tract bacterium uncovered as trigger for serious nervous system disease

October 3, 2016
Guillain-Barré syndrome (GBS) is an acute life-threatening disease of the nervous system that leads to sensory disturbances and acute flaccid paralysis. A group of researchers involving the University of Zurich has now shown ...

Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease, study finds

October 23, 2017
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a vaccine for respiratory syncytial ...

Respiratory tract infections in young children linked to asthma and worse lung function

September 10, 2017
Milan, Italy: Respiratory tract infections in young children are linked to an increased risk of asthma and worse lung function in later life, according to new research to be presented at the European Respiratory Society International ...

M. pneumoniae infection linked to Guillain-Barre syndrome

August 16, 2016
(HealthDay)—Mycoplasma pneumoniae infection is associated with Guillain-Barré syndrome (GBS), according to a study published online Aug. 4 in the Annals of Neurology.

Pneumonia bug distracts immune system

August 29, 2017
A Sydney researcher has discovered a common, pneumonia-causing bacterium can shed living proteins, and may use this ability as a defence against our immune system.

Recurrent viral respiratory tract infections during first six months and risk of T1 diabetes

May 3, 2016
In a study appearing in the May 3, 2016 issue of JAMA, Anette-Gabriele Ziegler, M.D., of Helmholtz Zentrum Munchen, Munich, Germany, and colleagues examined associations between infection types during the first 2 years of ...

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.